Teneligliptin and “Thorough QTc study”: thorough enough?

Samit GhosalDepartment of Endocrinology, Nightingale Hospital, Kolkata, IndiaI read with interest the “Thorough QTc study” with teneligliptin by Erande et al.1 It came as a surprise to me that the basic structure required to conduct such a trial as per the ICH E...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Ghosal S
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://doaj.org/article/e0bb67106fff4eed93e4707707127c4c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e0bb67106fff4eed93e4707707127c4c
record_format dspace
spelling oai:doaj.org-article:e0bb67106fff4eed93e4707707127c4c2021-12-02T05:40:19ZTeneligliptin and “Thorough QTc study”: thorough enough?1178-7007https://doaj.org/article/e0bb67106fff4eed93e4707707127c4c2019-07-01T00:00:00Zhttps://www.dovepress.com/teneligliptin-and-ldquothorough-qtc-studyrdquo-thorough-enough-peer-reviewed-article-DMSOhttps://doaj.org/toc/1178-7007Samit GhosalDepartment of Endocrinology, Nightingale Hospital, Kolkata, IndiaI read with interest the “Thorough QTc study” with teneligliptin by Erande et al.1 It came as a surprise to me that the basic structure required to conduct such a trial as per the ICH E14 recommendations for the industry was not followed.2 The recommended design to conduct such a trial was not universally followed (Table1).View the original paper by Erande and colleaguesGhosal SDove Medical PressarticleNot applicableSpecialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol Volume 12, Pp 1141-1142 (2019)
institution DOAJ
collection DOAJ
language EN
topic Not applicable
Specialties of internal medicine
RC581-951
spellingShingle Not applicable
Specialties of internal medicine
RC581-951
Ghosal S
Teneligliptin and “Thorough QTc study”: thorough enough?
description Samit GhosalDepartment of Endocrinology, Nightingale Hospital, Kolkata, IndiaI read with interest the “Thorough QTc study” with teneligliptin by Erande et al.1 It came as a surprise to me that the basic structure required to conduct such a trial as per the ICH E14 recommendations for the industry was not followed.2 The recommended design to conduct such a trial was not universally followed (Table1).View the original paper by Erande and colleagues
format article
author Ghosal S
author_facet Ghosal S
author_sort Ghosal S
title Teneligliptin and “Thorough QTc study”: thorough enough?
title_short Teneligliptin and “Thorough QTc study”: thorough enough?
title_full Teneligliptin and “Thorough QTc study”: thorough enough?
title_fullStr Teneligliptin and “Thorough QTc study”: thorough enough?
title_full_unstemmed Teneligliptin and “Thorough QTc study”: thorough enough?
title_sort teneligliptin and “thorough qtc study”: thorough enough?
publisher Dove Medical Press
publishDate 2019
url https://doaj.org/article/e0bb67106fff4eed93e4707707127c4c
work_keys_str_mv AT ghosals teneligliptinandldquothoroughqtcstudyrdquothoroughenough
_version_ 1718400326422233088